Seeking Alpha

Aegerion Pharmaceuticals (AEGR -10.1%) says it plans a public offering of 3.4M shares of common...

Aegerion Pharmaceuticals (AEGR -10.1%) says it plans a public offering of 3.4M shares of common stock at $14.75/share, as it looks to raise funds for activities related to the regulatory approval and commercialization of its lipid disorder treatment and lead product candidate lomitapide.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector